The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA (ctDNA) status and clinical outcomes in patients (pts) with previously untreated diffuse large B-cell lymphoma (DLBCL) in the POLARIX study.
 
Alex Francisco Herrera
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Adicet Bio; AstraZeneca/MedImmune; Bristol-Myers Squibb; Caribou Biosciences; Genentech/Roche; Genmab; Karyopharm Therapeutics; Merck; Pfizer; Regeneron; Seagen; Takeda; Tubulis GmbH
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Merck (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Samuel Tracy
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Laurie Helen Sehn
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Celgene/Bristol-Myers Squibb; Genmab; Gilead Sciences; Incyte; Janssen-Ortho; Kite, a Gilead company; Merck; Roche/Genentech; Sandoz-Novartis; Seagen; Teva
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Beigene; Celgene/Bristol-Myers Squibb; Genmab; Gilead Sciences; Incyte; Janssen; Kite, a Gilead company; Merck; Roche/Genentech; Sandoz-Novartis; Seagen; Teva; TG therapeutics
Research Funding - Roche/Genentech (Inst); Teva (Inst)
 
Fabrice Jardin
Honoraria - Abbvie/Genentech; Abbvie/Genentech; Celgene; Janssen; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche
 
Georg Lenz
Honoraria - Abbvie; ADC Therapeutics; AstraZeneca; Bristol-Myers Squibb; Constellation Pharmaceuticals; Genmab/Seattle Genetics; Gilead Sciences; Incyte; Janssen-Cilag; Novartis; Roche/Genentech; SOBI
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Bristol-Myers Squibb; Genase Therapeutics; Genmab/Seattle Genetics; Gilead Sciences; Hexal; Immagene; Incyte; Janssen-Cilag; Karyopharm Therapeutics; Lilly; Miltenyi Biomedicine; MorphoSys; Novartis; PentixaPharm; Roche/Genentech; Sobi
Research Funding - AGIOS; Aquinox; AstraZeneca; Bayer; Gilead Sciences; Janssen-Cilag; MorphoSys; Roche/Genentech; Verastem
Expert Testimony - Roche
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen-Cilag; Roche/Genentech
 
Marek Trneny
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Janssen; MorphoSys; Novartis; Roche; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Incyte; Janssen; MorphoSys; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Gilead Sciences; janssen; Roche; Takeda
 
Gilles A. Salles
Stock and Other Ownership Interests - Owkin
Honoraria - Abbvie; Bayer; Incyte; Regeneron
Consulting or Advisory Role - Abbvie; BeiGene; BMS; Debiopharm Group; Epizyme; Genmab; Incyte; incyte; Ipsen; Janssen; Kite/Gilead; Loxo/Lilly; Miltenyi Biotec; Molecular Partners; morphosys; Nordic Nanovector; Novartis; RAPT Therapeutics; Roche/Genentech; Takeda; Velosbio
 
Christopher Flowers
Stock and Other Ownership Interests - Foresight Diagnostics; N Power
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb/Celgene; Celgene; Curio Science; Denovo Biopharma; Epizyme; Foresight Diagnostics; Genentech/Roche; Genmab; Gilead Sciences; Karyopharm Therapeutics; MorphoSys; Pharmacyclics/Janssen; SeaGen; Spectrum Pharmaceuticals
Research Funding - 4D Pharma (Inst); Abbvie (Inst); Acerta Pharma (Inst); Adaptimmune (Inst); Alimera Sciences (Inst); Amgen (Inst); Bayer (Inst); Celgene (Inst); Cellectis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Guardant Health (Inst); Iovance Biotherapeutics (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Millennium (Inst); MorphoSys (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Sanofi (Inst); Takeda (Inst); TG Therapeutics (Inst); Xencor (Inst); ZIOPHARM Oncology (Inst)
 
Herve Tilly
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - ADC Therapeutics; Celgene/Bristol-Myers Squibb; Incyte; Roche
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Janssen
 
Jeff Porter Sharman
Employment - US Oncology Network
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Beigene; Beigene; Bristol-Myers Squibb; Genentech; Janssen Oncology; Lilly; Merck
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst)
 
Jonathan W. Friedberg
Research Funding - Enterome (Inst)
Patents, Royalties, Other Intellectual Property - Patient on bone marrow microenvironment signals (I)
 
Sandhya Balasubramanian
Employment - F. Hoffmann LaRoche
Stock and Other Ownership Interests - Abbvie
 
Vibha Raghavan
Employment - Roche
 
Jamie H. Hirata
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Calvin Lee
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Yanwen Jiang
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Franck Morschhauser
Honoraria - Chugai/Roche; Eisai; Roche/Genentech
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; epizyme; Genmab; Gilead Sciences; Novartis; Roche/Genentech; SERVIER